Hsbc Holdings PLC Buys 97,576 Shares of Astera Labs, Inc. $ALAB

Hsbc Holdings PLC boosted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 116.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 181,297 shares of the company’s stock after buying an additional 97,576 shares during the period. Hsbc Holdings PLC’s holdings in Astera Labs were worth $19,808,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Reflection Asset Management purchased a new position in Astera Labs during the fourth quarter worth $25,000. Smartleaf Asset Management LLC raised its stake in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the period. Aventura Private Wealth LLC purchased a new stake in shares of Astera Labs in the fourth quarter valued at $33,000. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in shares of Astera Labs in the 4th quarter worth about $33,000. Finally, Whipplewood Advisors LLC lifted its holdings in shares of Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after acquiring an additional 319 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Trading Up 3.5%

Shares of ALAB opened at $319.79 on Wednesday. The firm has a market capitalization of $54.82 billion, a P/E ratio of 216.07, a P/E/G ratio of 3.51 and a beta of 3.66. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a fifty day moving average price of $353.67 and a 200-day moving average price of $223.00.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter last year, the firm posted $0.33 EPS. The firm’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts predict that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of recent analyst reports. TD Cowen lifted their price target on shares of Astera Labs from $225.00 to $425.00 and gave the stock a “hold” rating in a research note on Monday, July 13th. Stifel Nicolaus increased their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Finally, JPMorgan Chase & Co. upped their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $282.00.

Insiders Place Their Bets

In related news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $200.16, for a total value of $28,012,592.16. Following the completion of the transaction, the chief executive officer directly owned 3,929,183 shares in the company, valued at approximately $786,465,269.28. This trade represents a 3.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,676,845 shares of company stock worth $444,928,806 in the last three months. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.